NCT Number: NCT01303757
A Novel Diet-Phenotype Interaction Affecting Body Weight
The primary aim of the study is to examine insulin secretion as an effect modifier of the efficacy of a low-fat vs. low-glycemic load diet for weight loss among overweight/obese young adults in an 18-month, prospectively stratified, multi-center randomized controlled trial.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–40 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Children's Hospital Boston, Boston, Massachusetts, United States
About this study
In recent years, diets of widely varying composition have been used in the treatment of obesity. While none of these diets has produced consistent, long-term weight loss, some individuals on virtually all types of diets do remarkably well. One explanation for this variation among individuals is differences in motivation and behavior. However, underlying biological differences may also play an important role. Previous work has identified insulin secretion (as quantified by serum insulin concentration at 30 minutes following a standard 75-gram oral glucose load) as an important biological determinant. This randomized-controlled, multi-center trial aims to test the hypothesis that insulin secretion will predict which type of diet will work best for each individual. A total of 160 obese young adults (18 to 40 years) will be assigned to one of two diets: low-fat (60% carbohydrate, 20% fat, 20% protein) or low-glycemic load (45% carbohydrate, 35% fat, 20% protein). Participants will be enrolled at two sites (Children's Hospital Boston or University of North Carolina-Chapel Hill) and assigned to diet groups according to baseline insulin secretion status. The protocol will include an intensive 6-month intervention period and a 12-month follow-up period. Registered dietitians will provide nutrition education and behavioral counseling during group workshops and scheduled telephone calls. In an effort to avoid confounding, close attention will be paid to control for treatment intensity, physical activity prescriptions, and behavioral methods between groups. The primary endpoint will be percent body fat by DXA scan. Secondary endpoints will include cardiovascular and diabetes risk factors. Repeated, 24-hour dietary and physical activity recall interviews will provide process data. Metabolomic profiling and molecular analysis of identified metabolites will be conducted to characterize phenotype and explore potential physiological mechanisms. A successful outcome of this work will inform the practice of "personalized" nutritional therapy, enhancing the ability to select the most efficacious weight loss diet for an individual based on underlying biological differences.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Aged 18 to 40 years.
- Body mass index (BMI) ≥ 27 kg/m2.
- Body weight ≤ 300 lb.
- Access to a working telephone.
- Clearance in writing from a primary care provider (i.e., physician or nurse practitioner) to rule out pre-existing medical conditions.
- Willing and able to attend group workshops (for dietary intervention) on specified evenings.
Exclusion criteria
- Physician diagnosis of a major medical illness or eating disorder.
- Chronic use of any medication that may affect study outcomes (e.g., insulin-sensitizing agents).
- Current smoking (i.e., 1 cigarette in the past week).
- Physical, mental, or cognitive handicaps that prevent participation.
- Another member of the family (i.e., first degree relative) or household participating in the study.
- Planning to relocate from current area of residence during the proposed timeframe for study participation.
- If female, planning to become pregnant during the 18 months of the study.
Treatment and study plan
Primary outcomes
-
Percent body fat by dual-energy x-ray absorptiometry (DXA)
Time frame: 18 months
Secondary outcomes
-
Triglyceride
Time frame: 18 months
-
HDL cholesterol
Time frame: 18 months
-
LDL cholesterol
Time frame: 18 months
-
C-reactive protein
Time frame: 18 months
-
Plasminogen Activator Inhibitor-1
Time frame: 18 months
-
Fasting blood glucose
Time frame: 18 months
-
Insulin resistance
Time frame: 18 months
-
Blood pressure
Time frame: 18 months
-
Trunk fat
Time frame: 18 months
Other outcomes
-
Serum insulin concentration 30 minutes following a standard 75-gram oral glucose load
Time frame: 18 months
Effect modification
-
Metabolomic profile
Time frame: 18 months
Effect modification
-
Insulin sensitivity
Time frame: 18 months
Effect modification
-
Abdominal-to-total fat ratio
Time frame: 18 months
Effect modification
-
Waist-to-hip ratio
Time frame: 18 months
Effect modification
Sponsors and collaborators
Lead sponsor
Boston Children's Hospital
Other
Collaborators
- Broad Institute of MIT and Harvard
- University of North Carolina, Chapel Hill
Registry information
Acronym: FRESH Start
Important dates
- Study start
- 2011
- Primary completion
- 2015
- Study completion
- 2015
- First posted
- Feb 25, 2011
- Registry last updated
- Feb 9, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Food is Medicine vs Lifestyle Medicine For Cardiovascular Kidney Metabolic (CKM) Syndrome
NCT06461273
Behavior, Body Weight
Newark, New Jersey, United States
View Trial DetailsPolyamine Treatment in Elderly Patients With Coronary Artery Disease
NCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial DetailsFeasibility Trial of Functional Clothing, Moderate Exercise, and Health Information for Stress Reduction and Behavior Change in Okinawa
NCT07204483
Behavior, Behavioral Symptoms
Naha, Okinawa, Japan
View Trial DetailsTime Restricted Eating (TRE) and High-Intensity Interval Training (HIIT) to Improve Health in Patients With Metabolic Syndrome (METS)
NCT06501001
Behavior, Body Weight
Toledo, Spain
View Trial Details